Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC)
Open Access
- 1 May 2020
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 79 (5), 605-611
- https://doi.org/10.1136/annrheumdis-2019-216736
Abstract
Objectives Using a prospective research design, we evaluated the association between acquisition of diarrhoeagenic Escherichia coli (DEC) and development of reactive arthritis (ReA) and other reactive musculoskeletal (MSK) symptoms among international travellers. Methods A total of 526 study participants were asked to provide pretravel and post-travel stool samples and fill in questionnaires (pretravel, post-travel and 3-week follow-up). A multiplex quantitative PCR assay was deployed to detect five DEC comprising enteroaggregative E. coli, enteropathogenic E. coli, enterotoxigenic E. coli, enterohaemorrhagic E. coli and enteroinvasive E. coli and Salmonella, Shigella, Campylobacter, Yersinia, and Vibrio cholerae. Multivariate analysis was employed to identify factors predisposing to MSK symptoms. New post-travel MSK symptoms reported by participants with DEC were assessed by phone interviews and, if needed, clinically confirmed. Results From among the total of 224 volunteers who returned all questionnaires and stool specimens, 38 (17.0%) reported MSK symptoms. Multivariate analysis revealed that acquisition of DEC was associated with MSK symptoms (OR 3.9; 95% CI 1.2 to 13.3). Of the 151 with only-DEC, four (2.6%) had ReA, two (1.3%) reactive tendinitis and three (2.0%) reactive arthralgia. ReA was mostly mild, and all patients with ReA were negative for human leucocyte antigen B27. Antibiotic treatment of travellers' diarrhoea did not prevent development of MSK symptoms. Conclusion A total of 17% of volunteers reported post-travel MSK symptoms. DEC acquisition was associated with an increased risk of developing them, yet the ReA incidence remained low and the clinical picture mild. Antibiotic treatment did not protect against development of MSK symptoms.Funding Information
- Suomen Kulttuurirahasto
- Sigrid Juséliuksen Säätiö
- Finnish Society for Rheumatology
- Finnish Governmental Subsidy of Health Science Research
- Scandinavian Society for Antimicrobial Chemotherapy Foundation
- Paulon Säätiö
This publication has 37 references indexed in Scilit:
- Post‐Infectious Sequelae of Travelers' DiarrheaJournal of Travel Medicine, 2013
- Reactive arthritis: does screening stools by polymerase chain reaction for Shiga toxin-producingEscherichia coli(STEC) make sense?Scandinavian Journal of Rheumatology, 2012
- Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoeaClinical Microbiology & Infection, 2011
- Reactive arthritisBest Practice & Research Clinical Rheumatology, 2011
- Microbial Etiology of Travelers' Diarrhea in Mexico, Guatemala, and India: Importance of Enterotoxigenic Bacteroides fragilis and Arcobacter SpeciesJournal of Clinical Microbiology, 2010
- Patient-reported complications associated with Campylobacter jejuni infectionEpidemiology and Infection, 2009
- Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based studyAnnals Of The Rheumatic Diseases, 2008
- Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosisAnnals Of The Rheumatic Diseases, 2001
- ANTIBODIES TO KLEBSIELLA PNEUMONIAE, ESCHERICHA COLIAND PROTEUS MIRABILISIN THE SERA OF PATIENTS WITH AXIAL AND PERIPHERAL FORM OF ANKYLOSING SPONDYLITISRheumatology, 1995
- Reiter's syndrome in an adolescent girlActa Paediatrica, 1994